Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF

被引:0
作者
Adamson, C. [1 ]
Welsh, P. [1 ]
Morrow, D. A. [2 ]
Docherty, K. F. [1 ]
Hammarstedt, A. [3 ]
Inzucchi, S. E. [4 ]
Kober, L. [5 ]
Kosiborod, M. N. [6 ]
Martinez, F. A. [7 ]
Ponikowski, P. [8 ]
Sabatine, M. S. [2 ]
Solomon, S. D. [2 ]
Sattar, N. [1 ]
Jhund, P. S. [1 ]
McMurray, J. J. V. [1 ]
机构
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] AstraZeneca, Gothenburg, Sweden
[4] Yale Univ, New Haven, CT USA
[5] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[6] Univ Missouri, Kansas City, KS USA
[7] Natl Univ Cordoba, Cordoba, Argentina
[8] Wroclaw Med Univ, Wroclaw, Poland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:913 / 913
页数:1
相关论文
共 50 条
[21]   Efficacy and safety of dapagliflozin in black, compared to white, patients with heart failure with reduced ejection fraction: Results from DAPA-HF [J].
Docherty, K. F. ;
Inzucchi, S. E. ;
Kober, L. ;
Kosiborod, M. N. ;
Martinez, F. A. ;
Bengtsson, O. ;
Ponikowski, P. ;
Sabatine, M. S. ;
Sjostrand, M. ;
Solomon, S. D. ;
Langkilde, A. M. ;
Jhund, P. S. ;
Mcmurray, J. J. V. John J. V. .
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 :56-56
[23]   Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial [J].
Butt, Jawad H. ;
Nicolau, Jose C. ;
Verma, Subodh ;
Docherty, Kieran F. ;
Petrie, Mark C. ;
Inzucchi, Silvio E. ;
Schou, Morten ;
Kosiborod, Mikhail N. ;
Langkilde, Anna Maria ;
Martinez, Felipe A. ;
Ponikowski, Piotr ;
Sabatine, Marc S. ;
Sjostrand, Mikaela ;
Solomon, Scott D. ;
Bengtsson, Olof ;
Jhund, Pardeep S. ;
McMurray, John J. V. ;
Kober, Lars .
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) :601-613
[24]   GROWTH DIFFERENTIATION FACTOR-15, CLINICAL OUTCOMES, AND THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: INSIGHTS FROM THE DAPA-HF TRIAL [J].
Berg, David ;
Docherty, Kieran F. ;
Talebi, Atefeh ;
Sattar, Naveed ;
Jarolim, Petr ;
Welsh, Paul ;
Jhund, Pardeep ;
Anand, Inderjit S. ;
De Boer, Rudolf A. ;
Kosiborod, Mikhail ;
Kober, Lars ;
Martinez, Felipe A. ;
O'Meara, Eileen ;
Ponikowski, Piotr ;
Schou, Morten ;
Solomon, Scott D. ;
Hammarstedt, Ann ;
Langkilde, Anna Maria ;
McMurray, John J. V. ;
Sabatine, Marc Steven ;
Morrow, David A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) :631-631
[25]   Translating findings from the landmark DAPA-HF study: a multinational cost-effectiveness analysis of dapagliflozin in the treatment of heart failure with reduced ejection fraction [J].
Mcmurray, J. J. V. ;
Mcewan, P. ;
Darlington, O. ;
Jhund, P. ;
Docherty, K. ;
Bohm, M. ;
Petrie, M. ;
Bergenheim, K. ;
Qin, L. .
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 :272-273
[26]   Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF [J].
Docherty, Kieran F. ;
Welsh, Paul ;
Verma, Subodh ;
De Boer, Rudolf A. ;
O'Meara, Eileen ;
Bengtsson, Olof ;
Kober, Lars ;
Kosiborod, Mikhail N. ;
Hammarstedt, Ann ;
Langkilde, Anna Maria ;
Lindholm, Daniel ;
Little, Dustin J. ;
Sjostrand, Mikaela ;
Martinez, Felipe A. ;
Ponikowski, Piotr ;
Sabatine, Marc S. ;
Morrow, David A. ;
Schou, Morten ;
Solomon, Scott D. ;
Sattar, Naveed ;
Jhund, Pardeep S. ;
McMurray, John J., V .
CIRCULATION, 2022, 146 (13) :980-994
[27]   High-Sensitivity Cardiac Troponin and the Efficacy of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial [J].
Berg, David D. ;
Sabatine, Marc S. ;
Sattar, Naveed ;
Jarolim, Petr ;
Welsh, Paul ;
Jhund, Pardeep S. ;
Anand, Inder ;
De Boer, Rudolf A. ;
Kosiborod, Mikhail ;
O'Meara, Eileen ;
Hammarstedt, Ann .
CIRCULATION, 2021, 144
[28]   Influence of Ejection Fraction on the Effect of Treatment in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) [J].
Solomon, Scott ;
DeMets, David L. ;
Inzucchi, Silvio E. ;
Kober, Lars ;
Kosiborod, Mikhail N. ;
Langkilde, Anna Maria ;
Martinez, Felipe ;
Bengtsson, Olof ;
Ponikowski, Piotr ;
Sabatine, Marc S. ;
Sjostrand, Mikaela ;
McMurray, John J. .
CIRCULATION, 2019, 140 (25) :E973-E973
[29]   Budget impact evaluation of the DAPA-HF trial: is dapagliflozin cost-saving for the treatment of heart failure with reduced ejection fraction? [J].
Qin, L. ;
Darlington, O. ;
Miller, R. ;
Mellstrom, C. ;
Mcewan, P. .
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 :305-305
[30]   Acute changes in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF [J].
Docherty, K. F. ;
Vaduganathan, M. ;
Inzucchi, S. E. ;
Kober, L. ;
Kosiborod, M. N. ;
Martinez, F. A. ;
Bengtsson, O. ;
Ponikowski, P. ;
Sabatine, M. S. ;
Sjostrand, M. ;
Solomon, S. D. ;
Langkilde, A. M. ;
Jhund, P. S. ;
Mcmurray, J. J. V. John J. V. .
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 :57-57